Patents by Inventor John Yelnosky

John Yelnosky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4745131
    Abstract: 1-Phenyl-3N-alkyl amidinoureas are useful in the treatment of Irritable Bowel Syndrome.
    Type: Grant
    Filed: June 12, 1986
    Date of Patent: May 17, 1988
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John Yelnosky, Ghulam N. Mir
  • Patent number: 4714707
    Abstract: Aryl substituted diazaheterocyclic amines and their use in the treatment of gastrointestinal motility dysfunctions.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: December 22, 1987
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4701457
    Abstract: Amidinoureas are disclosed as useful for the treatment of irritable bowel syndrome.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: October 20, 1987
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John Yelnosky, Ghulam N. Mir
  • Patent number: 4689335
    Abstract: A method for treating gastrointestinal motility dysfunctions using phenylheterocyclic guanidines and novel heterocyclic guanidine compounds.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: August 25, 1987
    Assignee: William H. Rorer, Inc.
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4611011
    Abstract: 1-Phenyl-3N-alkyl amidinoureas are useful in the treatment of irritable bowel syndrome.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: September 9, 1986
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, Ghulam N. Mir
  • Patent number: 4563456
    Abstract: Method for treating gastrointestinal motility dysfunctions using 1,2,4-triazines.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: January 7, 1986
    Assignee: William H. Rorer, Inc.
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4563460
    Abstract: A method for treating gastrointestinal motility dysfunctions using 2-amino-quinoline and -quinazoline derivatives.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: January 7, 1986
    Assignee: William H. Rorer, Inc.
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4563475
    Abstract: A method for the treatment of a gastrointestinal motility dysfunction using a nitrogen containing heterocyclyl substituted acetylguanidine.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: January 7, 1986
    Assignee: William H. Rorer, Inc.
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4562188
    Abstract: A method for the treatment of irritable bowel syndrome using a 1,3,5-triazin-2-one and a class of 6-amino and 6-mercaptyl-1,3,5-triazin-2-one compounds.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: December 31, 1985
    Assignee: William H. Rorer, Inc.
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky
  • Patent number: 4486439
    Abstract: A method for the preventive and curative treatment of coccidial infections in humans and other animals comprising the administration thereto of an amidinourea of amidinothiourea.
    Type: Grant
    Filed: September 16, 1982
    Date of Patent: December 4, 1984
    Assignee: William H. Rorer, Inc.
    Inventors: William L. Studt, Donald E. Kuhla, Billy J. Chou, John Yelnosky
  • Patent number: 4298608
    Abstract: 1,4-Disubstituted-1,2-dihydro-1,3,5-triazin-2-ones are used to block conduction of high frequency nerve impulses by selectively acting to substantially completely block high frequency impulses without significantly blocking conduction of a single impulse. The effect is reversible when the drug is withdrawn.
    Type: Grant
    Filed: April 11, 1980
    Date of Patent: November 3, 1981
    Assignee: William H. Rorer, Inc.
    Inventors: George A. Condouris, John Yelnosky, Richard L. Riley, Chong M. Won, George H. Douglas, William L. Studt
  • Patent number: 4285972
    Abstract: Scours in animals, particularly new-born calves, lambs, piglets and foals are treated with a compound containing an effective amount of an antidiarrheal amidinourea.
    Type: Grant
    Filed: August 13, 1979
    Date of Patent: August 25, 1981
    Assignee: William H. Rorer, Inc.
    Inventors: Billy J. Chou, John Yelnosky, Richard L. Riley
  • Patent number: 4279928
    Abstract: Multiple daily dosing with amidinoureas of the formula ##STR1## produces a significant and sustained decrease in blood pressure in humans.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: July 21, 1981
    Assignee: William H. Rorer, Inc.
    Inventors: Richard L. Riley, George H. Douglas, John Yelnosky
  • Patent number: 4203983
    Abstract: 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-ones and their pharmaceutically acceptable salts are used in the control of abdominal spasticity especially the treatment of spasmodic conditions of the gastrointestinal tract by administering an effective amount of the triazinone in suitable pharmaceutical dosage forms including oral or parenteral dosage forms compounded with pharmaceutically acceptable carrier materials to patients having spasmodic syndromes.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: May 20, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Chong M. Won
  • Patent number: 4203985
    Abstract: New compositions containing as the principle active ingredient a 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-one are used for remedial or prophylactic treatment of diarrhea and organic gastrointestinal disorders accompanied by diarrheal symptoms.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: May 20, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Dahyabhai M. Patel, Chong M. Won, Ronald L. Alioto
  • Patent number: 4198409
    Abstract: New compositions containing as the principle active ingredient a 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-one are used for remedial or prophylactic treatment of diarrhea and organic gastrointestinal disorders accompanied by diarrheal symptoms.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: April 15, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Dahyabhai M. Patel, Chong M. Won, Ronald L. Alioto
  • Patent number: 4198408
    Abstract: 1,4-Disubstituted-1,2-dihydro-1,3,5-triazin-2-ones are used to block conduction of high frequency nerve impulses by selectively acting to substantially completely block high frequency impulses without significantly blocking conduction of a single impulse. The effect is reversible when the drug is withdrawn.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: April 15, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: George A. Condouris, John Yelnosky, Richard L. Riley, Chong M. Won, George H. Douglas, William L. Studt